Sun Pharma gets USFDA nod to market generic Demadex tablets
Drugs manufacturer Sun Pharmaceutical Industries Ltd has said that US Food and Drug Administration has given permission to market generic version of Hoffman la Roche's Demadex, torsemide tablets pescribed for treating edema associated diseases.
By PTI |
MUMBAI: Drugs manufacturer Sun Pharmaceutical Industries Ltd on Wednesday said that US Food and Drug Administration has given permission to market generic version of Hoffman la Roche's Demadex, torsemide tablets pescribed for treating edema associated diseases.
Torsemide is a diuretic, indicated for the treatment of edema associated with congestive heart failure, renal disease, or hepatic disease, the company said in a filing to the Bombay Stock Exchange.
These torsemide tablets have annual sales of approximately 35 million dollars (Rs 139.26 crore) in the US.
The company's abbreviated new drug application would be available in tablet form in 5 mg, 10 mg, 20 mg and 100 mg strength, it said.
Use of torsemide tablets has been found to be effective for the treatment of hypertension alone or in combination with other antihypertensive agents, it said.
Shares of the company closed at Rs 1192.65 at the BSE, up 4.54 per cent from the previous close. Sun Pharma gets USFDA nod to market generic Demadex tablets
Torsemide is a diuretic, indicated for the treatment of edema associated with congestive heart failure, renal disease, or hepatic disease, the company said in a filing to the Bombay Stock Exchange.
These torsemide tablets have annual sales of approximately 35 million dollars (Rs 139.26 crore) in the US.
The company's abbreviated new drug application would be available in tablet form in 5 mg, 10 mg, 20 mg and 100 mg strength, it said.
Shares of the company closed at Rs 1192.65 at the BSE, up 4.54 per cent from the previous close.
Torsemide is a diuretic, indicated for the treatment of edema associated with congestive heart failure, renal disease, or hepatic disease, the company said in a filing to the Bombay Stock Exchange.
These torsemide tablets have annual sales of approximately 35 million dollars (Rs 139.26 crore) in the US.
The company's abbreviated new drug application would be available in tablet form in 5 mg, 10 mg, 20 mg and 100 mg strength, it said.
Use of torsemide tablets has been found to be effective for the treatment of hypertension alone or in combination with other antihypertensive agents, it said.
Shares of the company closed at Rs 1192.65 at the BSE, up 4.54 per cent from the previous close. Sun Pharma gets USFDA nod to market generic Demadex tablets
ADVERTISEMENT
Mumbai, Feb 27 (PTI) Drugs manufacturer Sun Pharmaceutical Industries Ltd today said that US Food and Drug Administration has given permission to market generic version of Hoffman la Roche's Demadex, torsemide tablets pescribed for treating edema associated diseases. Torsemide is a diuretic, indicated for the treatment of edema associated with congestive heart failure, renal disease, or hepatic disease, the company said in a filing to the Bombay Stock Exchange.
These torsemide tablets have annual sales of approximately 35 million dollars (Rs 139.26 crore) in the US.
The company's abbreviated new drug application would be available in tablet form in 5 mg, 10 mg, 20 mg and 100 mg strength, it said.
ADVERTISEMENT
Use of torsemide tablets has been found to be effective for the treatment of hypertension alone or in combination with other antihypertensive agents, it said. Shares of the company closed at Rs 1192.65 at the BSE, up 4.54 per cent from the previous close.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
